Editas Medicine
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Editas Medicine's past years’ income statements indicate that its last revenue has increased compared to the previous period by 296% to $78,123,000. The net income raised on -$153,219,000 and profit margin reached -196%. Total operating expenses were $247,304,000.

Profit Margin

Editas Medicine, Inc. (LSE:0IFK.L): Profit margin
2014 0 -13.68M
2015 1.62M -72.9M -4475.14%
2016 6.05M -97.18M -1605.53%
2017 13.72M -120.32M -876.49%
2018 31.93M -109.95M -344.28%
2019 20.53M -123.46M -601.36%
2020 90.73M -109.41M -120.59%
2021 25.54M -185.10M -724.66%
2022 19.71M -204.35M -1036.69%
2023 78.12M -153.21M -196.13%

0IFK.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
78.12M19.71M25.54M90.73M20.53M31.93M13.72M6.05M1.62M0
Cost of revenue
177.65M6.33M5.05M157.99M96.89M083.15M018.84M5.07M
Gross profit
-99.52M13.37M20.49M-67.26M-76.36M31.93M-69.43M6.05M-17.21M-5.07M
Operating exp.
Research and development
177.65M174.95M142.50M157.99M96.89M90.65M83.15M56.97M18.84M5.07M
Selling and marketing
0000000000
Total operating expenses
247.30M245.66M218.69M225.57M161.45M145.66M133.66M103.24M36.94M12.72M
Operating income
-169.18M-225.95M-193.14M-134.84M-140.92M-113.72M-119.93M-97.18M-35.31M-12.72M
Other income (expenses), net
15.96M5.51M644K18.86M7.17M328K-391K-57K-37.58M-962K
Income before tax
-153.21M-220.43M-192.50M-115.97M-133.74M-109.95M-120.32M-97.18M-72.9M-13.68M
Income tax expense
0-16.08M-7.39M-6.56M-10.28M-3.11M-1.11M-1.32M-37.77M-894K
Net income
-153.21M-204.35M-185.10M-109.41M-123.46M-109.95M-120.32M-97.18M-72.9M-13.68M
Earnings per share
Basic EPS
-2.02-2.98-2.74-1.87-2.47-2.33-2.98-3.02-2.04-0.89
Diluted EPS
-2.02-2.98-2.74-1.87-2.47-2.33-2.98-3.02-2.04-0.89
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source